Literature DB >> 16033587

A measure of the within-chromosome synergistic epistasis for Drosophila viability.

J M Rosa1, S Camacho, A García-Dorado.   

Abstract

In order to detect possible synergistic epistasis for viability in Drosophila melanogaster we assayed the relative viability of chromosomes II in: (i) panmixia, (ii) forced total homozygosity, and (iii) homozygosity for, on the average, half of their loci. As these genotypes were constructed using exactly the same set of chromosomes in the three cases, the design allows us to estimate the inbreeding depression rate at two different inbreeding levels in the absence of purging natural selection. Overall, no consistent synergistic epistasis was found. However, there was a small fraction of chromosomes whose severely deleterious effect when homozygous was almost significantly larger than expected from their viability when homozygous for half of their loci. This suggests occasional but important synergistic epistasis, which might confer evolutionary advantage to recombination in tightly linked genomes. Nevertheless, such epistasis is unlikely to be an evolutionary advantage driving the evolution of sexual anisogamous reproduction, as its contribution to overall viability is small when compared with the two-fold cost of anisogamy.

Entities:  

Mesh:

Year:  2005        PMID: 16033587     DOI: 10.1111/j.1420-9101.2005.00892.x

Source DB:  PubMed          Journal:  J Evol Biol        ISSN: 1010-061X            Impact factor:   2.411


  2 in total

1.  Increase of the spontaneous mutation rate in a long-term experiment with Drosophila melanogaster.

Authors:  Victoria Avila; David Chavarrías; Enrique Sánchez; Antonio Manrique; Carlos López-Fanjul; Aurora García-Dorado
Journal:  Genetics       Date:  2006-03-17       Impact factor: 4.562

2.  Accelerated inbreeding depression suggests synergistic epistasis for deleterious mutations in Drosophila melanogaster.

Authors:  Sara Domínguez-García; Carlos García; Humberto Quesada; Armando Caballero
Journal:  Heredity (Edinb)       Date:  2019-09-02       Impact factor: 3.821

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.